No Data
No Data
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Cellectar Biosciences Plunges on Pursuit of Strategic Options for Cancer Drug Candidate, 60% Workforce Cut
Cellectar Biosciences Cut to Perform From Outperform by Oppenheimer
Cellectar Biosciences Analyst Ratings
Nasdaq Surges Over 1%; US Inflation Rises In-Line With Expectations
Oppenheimer Downgrades Cellectar BioSciences(CLRB.US) to Hold Rating
Den the Dragon : Good my friend
李飞538 : Thank you for your daily dedication.
101726747 : ty
Den the Dragon : hit
Phuong999 : Thank you